Nasopharyngeal carcinoma (Q59344163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Nasopharyngeal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

author name string

Jonathan S T Sham

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

9476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

2041-2054

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

publication type of scholarly work

12 January 2020

review article

1 reference

Detection of subclinical riasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal carcinoma: an evaluation of 134 patients treated between 1971-1980

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

ULTRASTRUCTURE OF NASOPHARYNGEAL CARCINOMAS IN AMERICAN AND CHINESE PATIENTS; AN APPLICATION OF ELECTRON MICROSCOPY TO GEOGRAPHIC PATHOLOGY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Cells of origin of nasopharyngeal carcinoma: an electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Molecular diagnosis of Epstein-Barr virus-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Epstein-Barr virus in the pathogenesis of NPC.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Epstein-Barr virus and oncogenesis: from latent genes to tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Proposal for a new histopathological classification of the carcinomas of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Prognostic significance of keratinization in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal carcinoma in young patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese Men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Magnetic resonance imaging of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Role of bone scanning in detection of subclinical bone metastasis in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Staging Abdominal Ultrasonography in Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal Carcinoma: Role of Marrow Biopsy at Diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Computed tomography in nasopharyngeal carcinoma: Part II: Impact on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal carcinoma: review of how imaging affects staging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

MRI in recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Computed tomography findings of bony regeneration after radiotherapy for nasopharyngeal carcinoma with skull base destruction: implications for local control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A comparison of staging systems for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma. American Joint Committee on Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Megavoltage irradiation of epithelial tumors of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Treatment of stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

High-dose, high-precision treatment options for boosting cancer of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: Efficacy and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal cancer WHO type II-III: monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Timing of chemoradiotherapy and patient selection for locally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Management of local residual primary lesion of nasopharyngeal carcinoma: II. Results of prospective randomized trial on booster dose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Value of clinical follow-up for local nasopharyngeal carcinoma relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Distant metastases from nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Oral health condition in southern Chinese after radiotherapy for nasopharyngeal carcinoma: extent and nature of the problem.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Quantitative measurement of post-irradiation neck fibrosis based on the young modulus: description of a new method and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Carotid stenosis after radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Dysphagia in patients with nasopharyngeal cancer after radiation therapy: a videofluoroscopic swallowing study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after rad

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Pathological basis of surgery in the management of postradiotherapy cervical metastasis in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Split-palate approach for gold grain implantation in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

New approach to the nasopharynx: the maxillary swing approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Transcervico-mandibulo-palatal approach for surgical salvage of recurrent nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal carcinoma: treatment of neck node recurrence by radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Fractionated stereotactic radiosurgery for 50 patients with recurrent or residual nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A Simple Afterloading Applicator for Intracavitary Irradiation of Carcinoma of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A technique for interstitial nasopharyngeal brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Long term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

The infratemporal fossa approach for nasopharyngeal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Long-term Survival After Surgical Resection for Recurrent Nasopharyngeal Cancer After Radiotherapy Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Nasopharyngeal carcinoma with metastatic disease to mediastinal and hilar lymph nodes: an indication for more aggressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966698-6

7 January 2021

10.1016/S0140-6736(05)66698-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15950718%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference